References
- Rounsaville B J, Weissman M M, Crits‐Christoph K, et al. Diagnosis and symptoms of depression in opiate addicts. Arch Gen Psychiatry 1982; 39: 151–156
- Rounsaville B J, Kosten T R, Weissman M M, et al. Prognostic significance of psychopathology in treated opiate addicts. Arch Gen Psychiatry 1986; 43: 739–745
- Nunes E V, Quitkin F M, Donovan S J, et al. Imipra‐mine treatment of opiate‐dependent patients with depressive disorders. Arch Gen Psychiatry 1998; 55: 153–160
- Woody G E, O'Brien B A, Rickels K. Depression and anxiety in heroin addicts: a placebo‐controlled study of doxepin in combination with methadone. Am J Psychiatry 1975; 132: 447–450
- Petrakis I, Carroll K, Gordon L, et al. Fluoxetine treatment for dually diagnosed methadone maintained opioid addicts: a pilot study. J Addict Dis 1994; 13: 25–32
- Feiger A, Kiev A, Shrivastava R K, et al. Nefazodone vs. sertraline in outpatients with major depression: focus on efficacy, tolerability, and effects on sexual function and satisfaction. J Clin Psychiatry 1996; 57(suppl 2)53–62
- Armitage R, Yonkers K, Cole D, et al. A multicen‐ter, double‐blind comparison of the effects of nefazodone and fluoxetine on sleep architecture and quality of sleep in depressed outpatients. J Clin Psychopharmacol 1997; 17: 161–168
- Sharpley A L, Walsh A E S, Cowen P J. Nefazodone, a novel antidepressant, may increase REM sleep. Biol Psychiatry 1992; 31: 1070–1073
- Gillin J C, Rapaport M, Erman M K, et al. A comparison of nefazodone and fluoxetine on mood and on objective, subjective, and clinician‐rated measures of sleep in depressed patients: a double‐blind, 8‐week clinical trial. J Clin Psychiatry 1997; 58: 185–192
- Iribarne C, Berthou F, Baird S, et al. Involvement of cytochrome P450 3A4 enzyme in the N‐demethylation of methadone in human liver microsomes. Chem Res Toxicol 1996; 9: 365–373
- Richelson E. Pharmacokinetic drug interactions of new antidepressants: a review of the effects on the metabolism of other drugs. Mayo Clin Proc 1997; 72: 835–847
- Stewart J W, McGrath P J, Quitkin F M, et al. Relevance of DSM‐III depressive subtype and chronic‐ity of antidepressant efficacy in atypical depression. Arch Gen Psychiatry 1989; 46: 1080–1087